Economic modeling for the US of the cost-efficiency and associated expanded treatment access of conversion to biosimilar pegfilgrastim-bmez from reference pegfilgrastim

Ali McBride, Weijia Wang, Kim Campbell, Sanjeev Balu, Karen MacDonald, Ivo Abraham

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Economic modeling for the US of the cost-efficiency and associated expanded treatment access of conversion to biosimilar pegfilgrastim-bmez from reference pegfilgrastim'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences